D.Western Therapeutics Institute, Inc.
4576Growth MarketPharmaceuticals
2nd Quarter of FY2026/12Earnings Call
DW-5LBT projected sales volume exceeding initial estimates prompts renegotiation of contract terms; preparations for H-1337 Japan P3 ramp up through partnership with Senju Pharmaceutical
August 19, 2026 at 19:37 GMT+9